pharma · Heart Failure · Atrial Fibrillation · RYTM
Rhythm Pharmaceuticals Netherlands
Rhythm Pharmaceuticals Netherlands B.V.
Rhythm Pharmaceuticals Netherlands clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
BRIGHTLANDS CHEMELOT CAMPUS, VAN ITERSON BUILDING, BURGEMEESTER LEMMENSSTRAAT 352, Geleen, nl HQ
2014 Founded
10 Employees
Public company Type
RYTM · NYSE Ticker
Company details
- Status
- Public
- HQ
- BRIGHTLANDS CHEMELOT CAMPUS, VAN ITERSON BUILDING, BURGEMEESTER LEMMENSSTRAAT 352, Geleen, nl
- Founded
- 2014
- Employees
- 10
- Programs
- 73
- Drugs
- 38
- Patents
- 12
Rhythm Pharmaceuticals Netherlands projects
0 ClinicalTrials.gov programs sponsored by Rhythm Pharmaceuticals Netherlands.
Rhythm Pharmaceuticals Netherlands has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does Rhythm Pharmaceuticals Netherlands have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.